3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
5
Not yet recruiting
2
Completed
2
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Classical hematology
39
Breast
10
Other hematologic neoplasm
9
Plasma cell
4
Thoracic
3
Gastrointestinal
3
Other
2
Lymphoid
2
Gynecologic
1
Genitourinary
1
Conditions
Lymphoma
1600
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1283
Lymphoma, Non-Hodgkin
1231
Leukemia, Lymphocytic, Chronic, B-Cell
1090
Lymphoma, Follicular
979
Lymphoma, Large B-Cell, Diffuse
854
Leukemia
790
Hodgkin Disease
777
Lymphoma, Mantle-Cell
676
Leukemia, Myeloid, Acute
540
Burkitt Lymphoma
507
Lymphoma, B-Cell, Marginal Zone
490
Multiple Myeloma
483
Myelodysplastic Syndromes
371
Lymphoma, Large-Cell, Immunoblastic
366
Recurrence
365
Lymphoma, T-Cell, Cutaneous
313
Neoplasms
309
Waldenstrom Macroglobulinemia
307
Lymphoma, Large-Cell, Anaplastic
255
Mycosis Fungoides
252
Lymphoma, B-Cell
231
Sezary Syndrome
229
Blast Crisis
210
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
208
Myeloproliferative Disorders
205
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
189
Neoplasms, Plasma Cell
188
Leukemia, Myeloid, Accelerated Phase
186
Leukemia, Myeloid, Chronic-Phase
179
Interventions
Positron Emission Tomography Computed Tomography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Febrile Neutropenia
×
Lymphoid
×
Clear all
NCT03429387
2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA
Completed
147 enrolled
NCT01459653
2016-01-11
Monitor-GCSF
Sandoz
Completed
1,496 enrolled
120 charts